GlassScriptPhysician profile
Sundeep Kaur
NPI 1679976948
$5,701.14
in general payments reported to CMS, 2019-2025
25 companies · $2,327 in 2025
The $2,327 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $441 · 2021: $670 · 2022: $354 · 2023: $499 · 2024: $539 · 2025: $2,327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,324 · Entertainment: $40.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,323.71 |
| Entertainment | $40.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $2,220.12 | 2022-2025 | Optilight |
| Alcon Vision LLC | $1,152.07 | 2019-2025 | Dailies Total1, Precision 1, Dailies |
| Coopervision INC. | $440.91 | 2019-2023 | Myday Contact Lens |
| Visioneering Technologies, INC. | $361.21 | 2019 | |
| Sight Sciences, INC. | $185.90 | 2019-2024 | Tearcare System |
| Oculus, INC. | $155.77 | 2019 | |
| Lkc Technologies, INC. | $154.59 | 2023-2025 | |
| Aerie Pharmaceuticals, INC. | $122.24 | 2019 | |
| Topcon Healthcare, INC. | $106.66 | 2024 | |
| Bausch & Lomb Americas INC. | $98.98 | 2023-2025 | Infuse |
| Maculogix, INC. | $95.43 | 2020 | |
| Abbvie INC. | $81.19 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $79.67 | 2020-2024 | Acuvue |
| Abb Con-Cise Optical Group LLC | $77.29 | 2023 | Contact Lens, Spectacle Lenses |
| Tarsus Pharmaceuticals, INC. | $69.50 | 2024-2025 | Xdemvy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $56.00 | 2020-2021 | |
| Shire North American Group INC | $40.84 | 2019 | |
| Optos, INC. | $40.74 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $40.63 | 2025 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Eyevance Pharmaceuticals LLC | $26.13 | 2019 | |
| Oyster Point Pharma, INC. | $15.90 | 2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.33 | 2021 | |
| Dompe US, INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sundeep Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.